EPILEPSY, PROGRESSIVE MYOCLONIC 3
|
0.710 |
GeneticVariation
|
disease |
BEFREE |
Several small case series identified KCTD7 mutations in patients with a rare autosomal recessive disorder designated progressive myoclonic epilepsy (EPM3) and neuronal ceroid lipofuscinosis (CLN14).
|
30295347 |
2018 |
Neuronal Ceroid-Lipofuscinoses
|
0.350 |
GeneticVariation
|
disease |
BEFREE |
The two reported patients carrying novel pathogenic variants in KCTD7 gene presented with a remarkable phenotypic heterogeneity including: a) progressive myoclonus epilepsy without NCL-type lysosomal storages; b) progressive myoclonus epilepsy with lysosomal storages resembling NCL pattern (NCL14); c) progressive myoclonus epilepsy with epilepsia partialis continua.
|
30500434 |
2019 |
Neuronal Ceroid-Lipofuscinoses
|
0.350 |
Biomarker
|
disease |
BEFREE |
Whereas KCTD7 mutations have previously been linked to PME without lysosomal storage, this study clearly demonstrates that KCTD7 mutations also cause a rare, infantile-onset NCL subtype designated as CLN14.
|
22748208 |
2012 |
Neuronal Ceroid-Lipofuscinoses
|
0.350 |
GeneticVariation
|
disease |
BEFREE |
Fourteen distinct NCL subtypes (CLN1-CLN14) are known, and they are caused by mutations in different genes.
|
26443629 |
2016 |
Neuronal Ceroid-Lipofuscinoses
|
0.350 |
GeneticVariation
|
disease |
BEFREE |
Biallelic KCTD7 mutations define a neurodegenerative disorder with lipofuscin and lipid droplet accumulation but without defining features of neuronal ceroid lipofuscinosis or lysosomal storage disorders.
|
30295347 |
2018 |
Neuronal Ceroid-Lipofuscinoses
|
0.350 |
GeneticVariation
|
disease |
BEFREE |
The NCLs are clinically and genetically heterogeneous and more than 14 genetically distinct NCL subtypes have been described to date (CLN1-CLN14) (Haltia and Goebel, 2012 [1]).
|
23274885 |
2013 |
Movement Disorders
|
0.120 |
GeneticVariation
|
group |
BEFREE |
Varying levels of evidence support their roles in neurocognitive disorders (KCTD3), neurodevelopmental disease (KCTD7), bipolar disorder (KCTD12), autism and schizophrenia (KCTD13), movement disorders (KCTD17), cancer (KCTD11), and obesity (KCTD15).
|
31197948 |
2019 |
Movement Disorders
|
0.120 |
GeneticVariation
|
group |
BEFREE |
Patients with KCTD7 mutations can exhibit movement disorders or developmental regression before seizure onset, and are distinguished from similar disorders by an earlier age of onset.
|
30295347 |
2018 |
Seizures
|
0.110 |
GeneticVariation
|
phenotype |
BEFREE |
Patients with KCTD7 mutations can exhibit movement disorders or developmental regression before seizure onset, and are distinguished from similar disorders by an earlier age of onset.
|
30295347 |
2018 |
Cerebellar atrophy
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the KCTD7 gene have been associated with progressive myoclonus epilepsy and, in a single patient, with the so-called "Neuronal Ceroid Lipofuscinosis 14" (characterised by myoclonic seizures, cognitive regression, optic atrophy leading to visual loss, and progressive cortical and cerebellar atrophy).
|
30500434 |
2019 |
Developmental regression
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
Patients with KCTD7 mutations can exhibit movement disorders or developmental regression before seizure onset, and are distinguished from similar disorders by an earlier age of onset.
|
30295347 |
2018 |
Myoclonic Epilepsies, Progressive
|
0.090 |
GeneticVariation
|
disease |
BEFREE |
The two reported patients carrying novel pathogenic variants in KCTD7 gene presented with a remarkable phenotypic heterogeneity including: a) progressive myoclonus epilepsy without NCL-type lysosomal storages; b) progressive myoclonus epilepsy with lysosomal storages resembling NCL pattern (NCL14); c) progressive myoclonus epilepsy with epilepsia partialis continua.
|
30500434 |
2019 |
Myoclonic Epilepsies, Progressive
|
0.090 |
Biomarker
|
disease |
BEFREE |
KCTD7-related progressive myoclonus epilepsy.
|
27629772 |
2016 |
Myoclonic Epilepsies, Progressive
|
0.090 |
GeneticVariation
|
disease |
BEFREE |
Several small case series identified KCTD7 mutations in patients with a rare autosomal recessive disorder designated progressive myoclonic epilepsy (EPM3) and neuronal ceroid lipofuscinosis (CLN14).
|
30295347 |
2018 |
Myoclonic Epilepsies, Progressive
|
0.090 |
GeneticVariation
|
disease |
BEFREE |
Novel mutation in potassium channel related gene KCTD7 and progressive myoclonic epilepsy.
|
22606975 |
2012 |
Myoclonic Epilepsies, Progressive
|
0.090 |
Biomarker
|
disease |
BEFREE |
Thus, our data demonstrate that KCTD7 has an impact on K<sup>+</sup> fluxes, neurotransmitter synthesis and neuronal function, and that malfunction of the encoded protein may lead to progressive myoclonus epilepsy.
|
27742667 |
2016 |
Myoclonic Epilepsies, Progressive
|
0.090 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the potassium channel-related gene KCTD7 were described so far in a single family with progressive myoclonus epilepsy.
|
22638565 |
2012 |
Myoclonic Epilepsies, Progressive
|
0.090 |
GeneticVariation
|
disease |
BEFREE |
Mutations in KCTD7 are associated with progressive myoclonic epilepsy, but how KCTD7 regulates neural development and function remains poorly understood.
|
31175897 |
2019 |
Myoclonic Epilepsies, Progressive
|
0.090 |
GeneticVariation
|
disease |
BEFREE |
We have recently reported a homozygous nonsense mutation of KCTD7 in patients with a novel form of autosomal recessive progressive myoclonic epilepsy.
|
21710140 |
2011 |
Unverricht-Lundborg Syndrome
|
0.080 |
GeneticVariation
|
disease |
BEFREE |
This is the second family with PME caused by KCTD7 mutations, hence KCTD7 mutations might be a recurrent cause of PME.
|
22606975 |
2012 |
Unverricht-Lundborg Syndrome
|
0.080 |
GeneticVariation
|
disease |
BEFREE |
We have recently reported a homozygous nonsense mutation of KCTD7 in patients with a novel form of autosomal recessive progressive myoclonic epilepsy.
|
21710140 |
2011 |
Unverricht-Lundborg Syndrome
|
0.080 |
GeneticVariation
|
disease |
BEFREE |
Several small case series identified KCTD7 mutations in patients with a rare autosomal recessive disorder designated progressive myoclonic epilepsy (EPM3) and neuronal ceroid lipofuscinosis (CLN14).
|
30295347 |
2018 |
Unverricht-Lundborg Syndrome
|
0.080 |
GeneticVariation
|
disease |
BEFREE |
Screening of KCTD7 in a further 132 PME patients revealed four additional mutations (two missense, one in-frame deletion, and one frameshift-causing) in five families.
|
22693283 |
2012 |
Unverricht-Lundborg Syndrome
|
0.080 |
GeneticVariation
|
disease |
BEFREE |
Mutations in KCTD7 are associated with progressive myoclonic epilepsy, but how KCTD7 regulates neural development and function remains poorly understood.
|
31175897 |
2019 |
Unverricht-Lundborg Syndrome
|
0.080 |
GeneticVariation
|
disease |
BEFREE |
Whereas KCTD7 mutations have previously been linked to PME without lysosomal storage, this study clearly demonstrates that KCTD7 mutations also cause a rare, infantile-onset NCL subtype designated as CLN14.
|
22748208 |
2012 |